Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Moreno

Showing results (271-280 of 548) with videos related to

Pageof 55
Sort By:
BMC Medicine|November 8, 2021
Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancerMireia Obón-Santacana, Anna Díez-Villanueva, Maria Henar Alonso, et al.
European Journal of Human Genetics : EJHG|December 20, 2012
Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genesLídia Feliubadaló, Adriana Lopez-Doriga, Ester Castellsagué, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 14, 2025
Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization AnalysisElla Fryer, D Timothy Bishop, Peter T Campbell, et al.
BMC Genomics|July 29, 2024
Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiotaDavid Bars-Cortina, Elies Ramon, Blanca Rius-Sansalvador, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid TumorsRastislav Bahleda, Antoine Italiano, Cinta Hierro, et al.
The Journal of Pathology|November 21, 2012
Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitorLouise J Barber, Shahneen Sandhu, Lina Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2018
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032Neal Ready, Anna F Farago, Filippo de Braud, et al.
Journal of Medical Genetics|September 1, 2018
Multitrait genome association analysis identifies new susceptibility genes for human anthropometric variation in the GCAT cohortIván Galván-Femenía, Mireia Obón-Santacana, David Piñeyro, et al.
Clinical Lung Cancer|June 21, 2022
Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET TrialVictor Moreno, Desamparados Roda, Joanna Pikiel, et al.
International Journal of Cancer|July 16, 2013
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transitionPaul Roepman, Andreas Schlicker, Josep Tabernero, et al.
Pageof 55

Showing results (271-280 of 548) with videos related to

Sort By:
Pageof 55
BMC Medicine|November 8, 2021
Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancerMireia Obón-Santacana, Anna Díez-Villanueva, Maria Henar Alonso, et al.
European Journal of Human Genetics : EJHG|December 20, 2012
Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genesLídia Feliubadaló, Adriana Lopez-Doriga, Ester Castellsagué, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 14, 2025
Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization AnalysisElla Fryer, D Timothy Bishop, Peter T Campbell, et al.
BMC Genomics|July 29, 2024
Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiotaDavid Bars-Cortina, Elies Ramon, Blanca Rius-Sansalvador, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid TumorsRastislav Bahleda, Antoine Italiano, Cinta Hierro, et al.
The Journal of Pathology|November 21, 2012
Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitorLouise J Barber, Shahneen Sandhu, Lina Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2018
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032Neal Ready, Anna F Farago, Filippo de Braud, et al.
Journal of Medical Genetics|September 1, 2018
Multitrait genome association analysis identifies new susceptibility genes for human anthropometric variation in the GCAT cohortIván Galván-Femenía, Mireia Obón-Santacana, David Piñeyro, et al.
Clinical Lung Cancer|June 21, 2022
Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET TrialVictor Moreno, Desamparados Roda, Joanna Pikiel, et al.
International Journal of Cancer|July 16, 2013
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transitionPaul Roepman, Andreas Schlicker, Josep Tabernero, et al.
Pageof 55